Associations between levels of insulin-like growth factor 1 and sinusoidal obstruction syndrome after allogeneic haematopoietic stem cell transplantation
Open Access
- 24 April 2017
- journal article
- clinical trial
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 52 (6) , 863-869
Abstract
Allogeneic myeloablative haematopoietic stem cell transplantation (HSCT) is challenged by severe adverse events, as cytotoxic effects of the conditioning may result in systemic inflammation, leaky epithelial barriers and organ toxicities, contributing to treatment-related morbidity and mortality. We hypothesised that insulin-like growth factor-1 (IGF-1), a mediator of growth and proliferation of various tissues, may attenuate chemotherapy-induced tissue damage after HSCT. We prospectively measured plasma levels of IGF-1 and its binding protein 3 (IGFBP-3) in 41 patients undergoing myeloablative HSCT. IGF-1 and IGFBP-3 levels were inversely correlated with C-reactive protein and interleukin-6 levels post HSCT. In multivariate analyses, low levels of IGF-1 and IGFBP-3 before conditioning were associated with increased risk of developing sinusoidal obstruction syndrome (SOS; OR=5.00 per 1 SDS decrease in IGF-1 (95% CI: 1.45–16.67), P=0.011 and OR=5.00 (1.37–20.00), P=0.015, respectively). Furthermore, low pre-transplant levels of IGF-1 and IGFBP-3 were associated with increased fluid retention during the first 21 days post transplant (OR=7.69 (95% CI: 1.59–33.33), P=0.012, and OR=2.94 (1.03–8.33), P=0.045). These data suggest that high levels of IGF-1 and IGFBP-3 may have a protective effect against fluid retention and SOS, possibly by attenuating systemic inflammation, and may prove useful as predictive biomarkers of SOS.Keywords
This publication has 53 references indexed in Scilit:
- The role of the endothelium in the short-term complications of hematopoietic SCTBone Marrow Transplantation, 2011
- A systematic review of randomized controlled trials exploring the effect of immunomodulative interventions on infection, organ failure, and mortality in trauma patientsCritical Care, 2010
- Pro-inflammatory cytokines play a key role in the development of radiotherapy-induced gastrointestinal mucositisRadiation Oncology, 2010
- Hepatic Veno-Occlusive Disease following Stem Cell Transplantation: Incidence, Clinical Course, and OutcomeTransplantation and Cellular Therapy, 2010
- Graft-versus-host diseaseThe Lancet, 2009
- Reciprocal Association of Plasma IGF-1 and Interleukin-6 Levels With Cardiometabolic Risk Factors in Nondiabetic SubjectsDiabetes Care, 2008
- The role of pro-inflammatory cytokines in cancer treatment-induced alimentary tract mucositis: Pathobiology, animal models and cytotoxic drugsCancer Treatment Reviews, 2007
- Hematopoietic Stem-Cell TransplantationNew England Journal of Medicine, 2006
- Insulin-Like Growth Factor-1 as a Vascular Protective FactorCirculation, 2004
- Influence of bacterial endotoxin on the allogenicity of human endothelial cellsBone Marrow Transplantation, 1998